Evidence map›Paper›PMID 29629144›Full record

ArticleChemical science2018

Label-free Raman spectroscopy provides early determination and precise localization of breast cancer-colonized bone alterations.

Chi Zhang, Paul T Winnard, Sidarth Dasari, Scott L Kominsky, Michele Doucet, Swaathi Jayaraman, Venu Raman, Ishan Barman

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Molecular fingerprint of precancerous lesions in breast atypical hyperplasia.The Journal of international medical research · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chi ZhangDepartment of Mechanical Engineering , Johns Hopkins University , Whiting School of Engineering , Latrobe Hall 103 , Baltimore , MD 21218 , USA . Email: ibarman@jhu.edu ; Tel: +1-410-516-0656.
Paul T WinnardDivision of Cancer Imaging Research , Russell H. Morgan Department of Radiology and Radiological Science , Johns Hopkins University School of Medicine , 720 Rutland Avenue, Rm 340 Traylor Building , Baltimore , MD , USA 21205 . Email: vraman2@jhmi.edu ; Tel: +1-410-955-7492.
Sidarth DasariIndiana University School of Medicine , Indianapolis , IN , USA.
Scott L KominskyDepartment of Orthopaedic Surgery , Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Michele DoucetDepartment of Orthopaedic Surgery , Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Swaathi JayaramanDepartment of Orthopaedic Surgery , Johns Hopkins University School of Medicine , Baltimore , MD , USA.
Venu RamanDivision of Cancer Imaging Research , Russell H. Morgan Department of Radiology and Radiological Science , Johns Hopkins University School of Medicine , 720 Rutland Avenue, Rm 340 Traylor Building , Baltimore , MD , USA 21205 . Email: vraman2@jhmi.edu ; Tel: +1-410-955-7492.
Ishan BarmanDepartment of Mechanical Engineering , Johns Hopkins University , Whiting School of Engineering , Latrobe Hall 103 , Baltimore , MD 21218 , USA . Email: ibarman@jhu.edu ; Tel: +1-410-516-0656.ORCID 0000-0003-0800-0825
Johns Hopkins University · USIndianapolis Zoo · US

Funding

Wide-Field Short-Wave Infrared (SWIR) multiphoton (MP) tissue imagingP41EB015871 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SO, PETER T. · 2012 to 2021
$11.3M
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progressionR01CA207208 · NCI · JOHNS HOPKINS UNIVERSITY · PI RAMAN, VENU · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA207208NIBIB NIH HHS P41 EB015871
6 · The paper itself

Abstract

Breast neoplasms frequently colonize bone and induce development of osteolytic bone lesions by disrupting the homeostasis of the bone microenvironment. This degenerative process can lead to bone pain and pathological bone fracture, a major cause of cancer morbidity and diminished quality of life, which is exacerbated by our limited ability to monitor early metastatic disease in bone and assess fracture risk. Spurred by its label-free, real-time nature and its exquisite molecular specificity, we employed spontaneous Raman spectroscopy to assess and quantify early metastasis driven biochemical alterations to bone composition. As early as two weeks after intracardiac inoculations of MDA-MB-435 breast cancer cells in NOD-SCID mice, Raman spectroscopic measurements in the femur and spine revealed consistent changes in carbonate substitution, overall mineralization as well as crystallinity increase in tumor-bearing bones when compared with their normal counterparts. Our observations reveal the possibility of early stage detection of biochemical changes in the tumor-bearing bones - significantly before morphological variations are captured through radiographic diagnosis. This study paves the way for a better molecular understanding of altered bone remodeling in such metastatic niches, and for further clinical studies with the goal of establishing a non-invasive tool for early metastasis detection and prediction of pathological fracture risk in breast cancer.

Identifiers

PMID29629144
PMCPMC5869989
OpenAlexW2769606998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.